Indefinite Delivery Contract SPE2DR25D6041

The federal contract IDV award SPE2DR25D6041, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, is a $999,999,999 Indefinite Delivery Contract (IDC) to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This IDC serves as a primary vehicle for DLA Troop Support Medical to efficiently procure essential pharmaceutical and medical supplies, supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The original solicitation, a pre-solicitation notice for the DLA Troop Support Medical Supply Chain's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), aims to establish multiple regional prime vendor contracts to provide worldwide pharmaceutical support to various DoD customers. The procurement, estimated at $30.3 billion, will be a firm-fixed price, requirements-type contract with a 30-month base period and three 30-month option periods. The awards will be made on a regional basis to at least three different contractors, with separate distribution fees for brand/generic and specialty pharmaceuticals to support normal and contingency operations globally.